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Microvesicles are nano-sized lipid vesicles released by all cells in vivo and in vitro.They are
released physiologically under normal conditions but their rate of release is higher under
pathological conditions such as tumors. Once released they end up in the systemic cir-
culation and have been found and characterized in all bioﬂuids such as plasma, serum,
cerebrospinal ﬂuid, breast milk, ascites, and urine. Microvesicles represent the status of
the donor cell they are released from and they are currently under intense investigation
as a potential source for disease biomarkers. Currently, the “gold standard” for isolating
microvesicles is ultracentrifugation, although alternative techniques such as afﬁnity puriﬁca-
tion have been explored. Viscosity is the resistance of a ﬂuid to a deforming force by either
shear or tensile stress.The different chemical andmolecular compositions of bioﬂuids have
an effect on its viscosity and this could affect movements of the particles inside the ﬂuid.
In this manuscript we addressed the issue of whether viscosity has an effect on sedimen-
tation efﬁciency of microvesicles using ultracentrifugation.We used different bioﬂuids and
spiked them with polystyrene beads and assessed their recovery using the Nanoparticle
Tracking Analysis. We demonstrate that MVs recovery inversely correlates with viscosity
and as a result, sample dilutions should be considered prior to ultracentrifugation when
processing any bioﬂuids.
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INTRODUCTION
Exosomes are nano-sized vesicles (MVs; 30–100 nm) of endoso-
mal origin produced by different parental cells (Keller et al., 2006;
Skog et al., 2008; Muralidharan-Chari et al., 2010). Nanoparticles
formed through membrane budding are also called microvesicles
and their corresponding process of formation is called microvesic-
ulation (Muralidharan-Chari et al., 2010). Their sizes differ from
30 nm in diameter and have been reported up to 5μm, the former
including the more homogenous population of exosomes released
from multivesicular bodies (MVBs) and the latter shedding from
the plasmamembranewhich are commonly referred to asMVs (Di
Vizio et al., 2009; Théry et al., 2009). In this article, we will refer to
all types of shed vesicles under the common term of microvesicles
(MVs).
Microvesicles have been extensively studied in serum and cul-
ture media from a variety of tumors (Balaj et al., 2011; Kouman-
goye et al., 2011); a great body of evidence shows that they can be
secreted into the extracellular space and are involved in intercellu-
lar communication by transferring functional proteins and RNA
molecules between cells (Skog et al., 2008; Grange et al., 2011;
Yang et al., 2011). MVs are also known to carry antigens from
microorganisms like viruses and bacteria and can be potential
biomarkers for a variety of diseases (Jayachandran et al., 2011;
Raymond et al., 2011). MVs are found in different bioﬂuids such
as plasma (Ashcroft et al., 2012), serum (Dalton, 1975), cultured
media (CM; Bastida et al., 1984), saliva (Keller et al., 2011), breast
milk (Hata et al., 2010), amniotic ﬂuid (Keller et al., 2011), and
urine (Wiggins et al., 1987).
A variety of methods have been utilized to isolate microvesi-
cles including sucrose gradient, ultracentrifugation, Exoquick™,
microﬁltration, and immune afﬁnity capturemethod (Taylor et al.,
2011; Tauro et al., 2012). A standardized method for isolation and
assessment of MVs from various body ﬂuids and culture media
has not yet been established and hinders reproducible studies
for downstream analysis of isolated MVs (Yuana et al., 2011).
Ultracentrifugation is considered the “gold standard” for harvest-
ing microvesicles, though inconsistencies have been reported in
reproducibility and repeatability of the data. Ultracentrifugation
protocols vary across users and this leads to inconsistencies in
recovery of MVs (Sustar et al., 2011; Taylor et al., 2011; Tauro
et al., 2012).
Viscosity of a ﬂuid is the resistance of a ﬂuid that is being
deformedby either shear or tensile stress.Due todifferent chemical
and/or molecular compositions, the makeup of different bioﬂuids
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will result in their varying viscosities. Thismanuscript explores the
recovery of MVs derived from different bioﬂuids (serum, plasma,
and culture media) with different viscosities, using ultracentrifu-
gation. To the best of our knowledge, this is the ﬁrst study to assess
this parameter.
MATERIALS AND METHODS
SAMPLES AND PRELIMINARY SAMPLE PREPARATION
In this study we used biobanked plasma and serum as well as
CM from HEK-293T cells. Whole blood samples were obtained
from healthy volunteers upon approved IRB protocols at Mass-
achusetts General Hospital and Harvard Medical School. Serum
samples were collected in 10ml tiger top tubes (BD vacutainer),
allowed to coagulate at room temperature for 30min and spun
at 1,300× g for 10min to separate serum from coagulated blood.
The serum was then ﬁltered through a 0.8-μm ﬁlter, aliquoted
into 2ml cryovials, and stored at −80˚C. Plasma was collected
into EDTA-containing tubes (BD vacutainer), spun at 1,500× g
for 10min to separate plasma from the buffy coat. Plasma was
then transferred to a clean tube and ﬁltered through a 0.8-
μm ﬁlter and stored at −80˚C until further processing. Culture
media was collected from HEK-293T cells, cultured for 48 h in
MV-depleted media, and spun at 300× g for 10min. The super-
natant was transferred to a clean tube and spun at 2,000× g for
15min, ﬁltered through a 0.8-μm ﬁlter and stored at −80˚C.
As controls, polystyrene beads (Thermo Scientiﬁc, Fremont,
USA) with the speciﬁc diameter of 100 nm were used to make
control samples (plasma+ beads, serum+ beads, CM+ beads,
PBS+ beads). Two microliters of serum, plasma, CM, and PBS
were spiked with a total of 7.22× 1010 polystyrene beads with-
out any pretreatment and used for ultracentrifugation. A total of
seven samples which included three samples and four controls
were used in this study. We use the term MVs for the plasma,
CM, and serum without beads and microparticles (MPs) as a
term for mixture of MVs of each bioﬂuid plus synthetic added
beads.
ULTRACENTRIFUGATION
At the time of analysis 2ml of serum, plasma, CM, serum+ beads,
plasma+ beads, and PBS+ beads were thawed at room tempera-
ture for ultracentrifugation. We deﬁned “pre-ultracentrifugation”
(pre-UC) as aliquots of each sample prior ultracentrifugation,
obtained after vortexing and used for quantity measurement of
MVs/MPs. All samples were ultracentrifuged at 100,000× g for
90min in a Optima Max-XP, ﬁxed angle MLA-55 rotor (k fac-
tor= 116; Beckman Coulter, Miami, FL, USA), at 4˚C. After ultra-
centrifugation,pellets of sampleswere collected, and re-suspended
in 50μl PBS and now considered as “post-ultracentrifugation”
(post-UC) aliquots of each sample post-ultracentrifugation, used
for quantity measurement of MVs/MPs.
NANOSIGHT
Concentration and size analysis of MVs/MPs
The concentration of MVs/MPs for pre-UC samples and post-UC
was identiﬁed by measuring the rate of Brownian motion using
the NanoSight LM10 system (NanoSight, Amesbury, UK) sup-
plemented with a fast video capture and Nanoparticle Tracking
Analysis (NTA) software. The instrument was calibrated based on
NanoSights’s protocol. The samples were measured for 30 s with
manual shutter and gain adjustments. Measurements were made
for each sample in triplicate after re-calibration of instrument as
suggested by NanoSight. NTA was used to measure particle size
(measured in nanometers); Pre-UC, Post-UC, and supernatant
samples were measured at room temperature in triplicate after cal-
ibration of the instrument based on the manufacturer’s protocol.
Each measurement repeated for three times.
VISCOMETER
Relative viscosities of pre-UC samples (serum, plasma, CM, and
PBS) were measured using an Ostwald-type viscometer (Cannon
Instrument Co., State College, PA, USA) at constant tempera-
ture as described by Fahey et al. (1965), based on time of ﬂow
through a volumetric capillary. The viscosity of each liquid (η1)
was determined using the following equation:
η1 =
(
ρ1t1
ρ2t2
)
η2,
where, ρ1 = density of unknown liquid, ρ2 = density of other liq-
uids (water), t 1 = time of the other liquids, t 2 = time of the known
liquid,η2 = viscosity of known liquid.We used theAmerican Soci-
ety for Testing and Materials (ASTM) standards for measuring
dynamic viscosity, centipoise (cP).
Statistical analysis
Three measurements (concentration, size, and diffusion coefﬁ-
cient) per sample were generated from the NanoSight instrument
for pre-UC and post-UC. Data was averaged and the standard
deviation was calculated. The sedimentation efﬁciency is deﬁned
as the difference between initial MVs’/MPs’ amount and result-
ing pellet amount of microvesicles. The sedimentation efﬁciency
of MVs/MPs in the samples was analyzed by one-way ANOVA
(Post hoc Tukey). Only the data with normal distribution (assessed
by the Kolmogorov–Smirnov test) were used. A value of p< 0.05
was considered signiﬁcant. Statistical analyses were performed
by using SPSS 15.0 (SPSS Inc., Chicago, USA). The error bars
displayed on the NTA graphs were obtained by the standard devi-
ation of the different measurements of each sample. All data is
represented as mean± standard deviation (SD).
RESULTS
HIGHER VISCOSITY RESULTS IN LOWER SEDIMENTATION EFFICIENCY
Table 1 summarizes the mean and standard deviation of pre-UC
concentration, post-UC concentration, and sedimentation efﬁ-
ciency for each experimental sample. We noticed a signiﬁcant
difference between sedimentation efﬁciency of plasma, serum and
culture media (p< 0.001). The viscosity of the plasma, serum,
CM, and PBS were 1.65, 1.4, 1.1, and 1.0 cP, respectively. The
Pearson correlation was −0.912 (p< 0.001), indicating that a
greater viscosity leads to lower sedimentation efﬁciency. The sed-
imentation efﬁciency of plasma with 1.65 cP viscosity was lower
because of higher viscosity in comparison to serum (1.4 cP), but
the difference was not statistically signiﬁcant (p> 0.05). Figure 1,
illustrates the comparisonof pre-UCMVs/MPswithpost-UCcon-
centration. It shows that in spite of lower initial concentration
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Table 1 | Evaluation of microvesicles/microparticles concentration (particles/ml) and viscosity before and after ultracentrifugation.
Biofluids (particles/ml) Mean of pre-UC
concentration
Mean of post-UC
concentration
Mean of sedimentation
efficiency
Std. deviation Viscosity (cP)
SAMPLES
Plasma 3.1 × 1012 7.3 × 1010 −3.0 × 1012 1.9 × 1011 1.65
Serum 3.0 × 1012 7.4 × 1010 −2.9 × 1012 4.0 × 1010 1.4
Culture media 5.3 × 1010 2.0 × 1010 −3.3 × 1010 5.7 × 109 1.1
CONTROLS
Plasma+beads 3.5 × 1012 2.0 × 1010 −3.5 × 1012 4.0 × 1011 1.65
Serum+beads 3.5 × 1012 1.1 × 1011 −3.4 × 1012 5.5 × 1010 1.4
Culture media+beads 9.0 × 1010 2.2 × 1010 −6.8 × 1010 1.1 × 1010 1.1
PBS+beads 6.9 × 1010 1.5 × 1010 −5.4 × 1010 1.6 × 1010 1.0
FIGURE 1 | Assessment of microvesicles/microparticles concentration (particles/ml) before and after ultracentrifugation. Bar graph represent the
concentration (particles/ml) of MVs/MPs pre-UC (black) and post-UC (gray;Y axis) for different tested samples and controls (X axis) along with viscosity of each
ﬂuid (cP).
of pre-UC MVs, the sedimentation efﬁciency was higher in CM
when comparing MVs’ quantities pre-UC with post-UC. Also
depicted in Figure 1, due to differences in viscosity of plasma
and serum when compared to CM, the differences between pre-
UC and post-UC was higher in CM when compared to MV
quantities (p< 0.05). This trend is also seen in plasma+ beads
and serum+ beads versus media+ beads (p< 0.05), because of
plasma and serum’s greater viscosity. There were no signiﬁcant dif-
ferences between sedimentation efﬁciency of PBS + beads and cul-
ture media+ beads pre-UC and post-UC.As presented by Table 1,
the less viscous ﬂuids (PBS and CM) have higher sedimentation
efﬁciency.
SIZE DISTRIBUTION OF PRE-UC, POST-UC, AND SUPERNATANT
As shown in Table 2, the mean size± SD (nm) of the MVs/MPs
in both plasma and serum were found to be signiﬁcantly larger
in Post-UC (plasma= 134.3± 11.2 nm; serum= 131.3± 2.9 nm)
compared to Pre-UC (plasma= 84.0± 2.6 nm; serum= 102.0±
6.0 nm; p< 0.05). Difference between the size of MVs in CM pre-
UC (mean± SD of 107.0± 7.0 nm) and post-UC (mean± SD
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Table 2 | Evaluation of microvesicles/microparticles size pre-UC and post-UC.
Pre-UC MVs/MPs size
(mean±SD)nm
Post-UC MVs/MPs size
(mean±SD)nm
pValue Supernatant MVs/MPs
size (mean±SD)nm
SAMPLES
Plasma 84.0±2.6 134.3±11.2 0.011a 93.7±8.9
Serum 102.0±6.0 131.3±2.9 0.028a 100.3±2.1
Culture media 107.0±7.0 118.0±7.9 0.283 111.3±1.2
CONTROLS
Plasma+beads 96.0±19.31 139.0±6.6 0.028a 97.0±22.8
Serum+beads 106.0±5.59 120.7±5.8 0.075 104.7±4.9
Culture Media+beads 113.0±3.0 129.3±2.3 0.003a 116.3±3.8
PBS+beads 160.0±13.0 115.7±7.4 0.017a 122.0±1.7
aIndicates signiﬁcant differences in p value.
of 118.0± 7.9 nm) were insigniﬁcant. Additionally, MVs in the
supernatant of plasma and serum samples were smaller in
diameter when compared to same MVs post-UC (mean± SD
of supernatant: plasma= 93.7± 8.9 nm, serum= 100.3± 2.1 nm;
mean± SD of Post-UC samples: plasma= 134.3± 11.2 nm;
serum= 131.3± 2.9 nm; Table 2). Also, PBS+ beads showed
a signiﬁcant decrease in average size of MPs post-UC
(mean± SD of pre-UC= 160.0± 13.0 versus mean± SD of post-
UC= 115.7± 7.4; p< 0.05). Figure 2 shows the NanoSight distri-
bution of MVs for plasma pre-UC and post-UC.
DISCUSSION
Microvesicles are emerging as a source of potential biomarkers
with putative prognostic and diagnostic value. One of the inter-
ests in the ﬁeld is to use MVs in a format that could detect initial
stages of disease, and accurately predict risk assessment andpatient
response to therapy. In this study we have examined how viscosity
affects sedimentation of MVs using ultracentrifugation. A ﬂuid is
termed viscous when the internal frictions are high and as a result,
it takes a great deal of energy for particles to initiate and sustain
their motion. Viscosity increases with decreasing temperature and
most ultracentrifugation steps are carried at +4˚C, the highest
water density, which suggests that viscosity is at its highest. Vis-
cosity also increases with pressure. Hydrostatic pressure increases
up to 200 bar/min in a sample spun at 50,000 rpm (Wattiaux
et al., 1971) and this should be taken into account when spin-
ning/comparing different bioﬂuids, assuming all other conditions
are kept equal. Here we used a viscometer to determine the“ﬂuid’s
resistance to ﬂow”which is deﬁned as viscosity. The strain rates are
deﬁned by the geometry of the instrument and the corresponding
stresses are deﬁned by the ﬂuid’s resistance to ﬂow.When one vari-
able is ﬁxed and known, the other forcewill dependon the viscosity
of the ﬂuid. Our results demonstrated that ultracentrifugation of
MVs is greatly affected by the viscosity of the bioﬂuid used. Plasma
had the highest viscosity (1.65 cP), followed by serum (1.4 cP), cul-
ture media (1.1 cP), and lastly PBS (1.0 cP). The viscosity of serum
and plasma were concordant with Tangney et al. (1997).
We found that viscosity has a signiﬁcant correlation with the
recovery of MVs/MPs. Because plasma has more proteins, e.g.,
ﬁbrinogen and other clotting factors, the internal frictions are
high and as a result, it requires more energy for particles to move
(Tangney et al., 1997). The same extrapolation may be attributed
to serum because, although it lacks clotting factors, it has other
proteins that increase its internal friction when compared with
less viscous ﬂuids like culture media and PBS. The sedimentation
efﬁciency of plasma was lower because of higher viscosity in com-
parison to serum and culture media. Culture media had a viscosity
very close to that of PBS and a higher number of MVswere pelleted
in culture media. These results were conﬁrmed when the samples
were spiked with 100 nm polystyrene beads. The data suggests that
viscosity is an important parameter to considerwhenworkingwith
a bioﬂuid where a lower viscous ﬂuid yields more MVs in the pel-
let, and that comparison of different bioﬂuids should be avoided
unless samples have been diluted to reach similar viscosity values.
Additionally, the result of this study showed that the average
size of the MVs increased signiﬁcantly after ultracentrifugation
in plasma and serum (p< 0.05); while average size of culture
media derived MVs increased insigniﬁcantly. The average size of
pelleted beads derived from PBS+ beads, the less viscous ﬂuid,
decreased signiﬁcantly (p< 0.05). This ﬁnding contradicts the
belief that plasma/serumhasMVs that are larger in size in compar-
ison with cell lines. It may indicate that longer ultracentrifugation
time is needed because of viscosity, providing the capability of
extracting smaller particles from plasma and serum. Another fac-
tor that should be taken into account is sedimentation stability
(streaming) which affects both accuracy and resolution. Stream-
ing, a factor that is related to Brownian motion of small particles,
causes the reported size distribution to be larger than actual size
distribution (Scott et al., 2005). MVs derived from plasma and
serum had smaller sizes that reﬂect more Brownian motion dur-
ing sedimentation, which could lead to reduced resolution and
sedimentation efﬁciency. Another factor that could lead to greater
MVs’ diameter is lipoprotein fusion; Ala-Korpela et al. (1998)
assessed particle fusion based on ﬂuorescent resonance energy
transfer and showed that lipoprotein particle fusion could occur
after sequential ultracentrifugation.
The following formula considers the centrifugal force, buoy-
ancy, and Stokes law which governs the sedimentation velocity of
a spherical particle:
v = Δρd
2a
18η
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FIGURE 2 | Size distribution (nm) and concentration (particles/ml)
from NTA measurements of a representative plasma samples.Three
dimensional graph illustrating size versus intensity (relative frequency of
each size range among the entire population of MVs) versus concentration
(particles/ml) of microvesicles from plasma. (A) Plasma MVs
Pre-UC – Average size of plasma MVs were 73 nm before
ultracentrifugation; 3D graph representing particle size versus intensity
versus concentration (particles/ml) of microvesicles before
ultracentrifugation (B) Plasma MVs Post-UC – Average size of plasma MVs
were 137 nm after ultracentrifugation; 3D graph representing particle size
versus intensity versus concentration (particles/ml) of microvesicles before
ultracentrifugation.
Where Δρ is the difference in densities of the microparticles and
the medium, d is the effectual diameter of the MVs, a is the accel-
eration of the centrifugal force generated in the centrifuge rotor,
and η is the viscosity of the medium (Sustar et al., 2011). Based
on this formula, along with the effect of ultracentrifugation force
and density of MVs, larger particles would sediment more effec-
tively in the same conditions. Also, according to Scott et al. (2005),
materials with higher densities (for example higher concentration
of MVs) have additional instability after sedimentation, which
cause pelletted MVs to detach and return into supernatant. This
could be a reason for lower efﬁciency and smaller average size
of MVs/MPS observed in plasma and serum (Scott et al., 2005;
Sustar et al., 2011). According to the formula, there are many
other factors that could affect sedimentation efﬁcacy such as dif-
ference between density of MVs and ﬂuid, centrifugal force (g ),
temperature, type of rotor (ﬁxed angle versus swing out) and time;
further studies are required to assess each factor along with their
synergism to improve efﬁcacy of ultracentrifugation protocol. As
mentioned above, another factor that should be taken into account
is the great likelihood of MVs/MPs fusion, based on natural stick-
iness of MVs/MPs, which could be inﬂuenced by their different
derived media and its buffer characteristics such as salt con-
centration, and ionic contents (Balaj et al., 2011; Jayachandran
et al., 2012). Follow-up studies exploring the differences in MVs
concentration and size over a range of RCFs (e.g., 100K, 150K,
200K× g ), various ultracentrifugation time spans, and different
rotors and subsequently different k factors, investigating the sta-
bility of vesicles isolated at those conditions could be of great
importance.
In conclusion, by comparing concentration and size of MVs
in different bioﬂuids, we determined that viscosity of bioﬂuids
could signiﬁcantly affect sedimentation efﬁciency. Also, this study
revealed that the size of MVs in more viscous bioﬂuids signif-
icantly increase after ultracentrifugation. Considering MVs and
their extensive diagnostic and therapeutic potential, more sys-
tematic research studies regarding the standardization of isolation
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protocols and identiﬁcation of effective factors for sedimentation
efﬁciency are necessary.
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